CYTX - Cytori Therapeutics Inc.
Previous close
0.2077
0.208 100.000%
Share volume: 0
Last Updated: Fri 26 Jul 2019 10:00:00 PM CEST
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
10%
Profitability
6%
Dept financing
39%
Liquidity
4%
Performance
8%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 2015 - 2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-61.59%
Return on assets
-17.41%
Return on sales
-657.87%
Return on invested capital
58.58%
Total debt ratio
70.73%
Debt ratio change over timeo
-1.03%
Current Ratio
1.07%
Quick Ratio
0.81%
Cash Position Ratio
0.72%
Short-term ratios 2018 - 2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-69.99%
Return on assets
-14.65%
Return on sales
-437.34%
Return on invested capital
135.82%
Total debt ratio
79.39%
Debt ratio change over timeo
-0.37%
Current Ratio
0.51%
Quick Ratio
0.34%
Cash Position Ratio
0.3%
Last quarter ratios 2019
The data are presented for the financials results of the last quarter.
Return on equity
-81.67%
Return on assets
-15.19%
Return on sales
-531.72%
Return on invested capital
147.13%
Total debt ratio
84.33%
Debt ratio change over time
0.21%
Current Ratio
0.46%
Quick Ratio
0.3%
Cash Position Ratio
0.21%
Performance ratios (change over 4 years) 2015 - 2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-100.02%
Return on assets
-96.82%
Return on sales
74.7%
Return on invested capital
-9.54%
Total debt ratio
-103.21%
Debt ratio change over time
-1.03%
Current Ratio
-1.52%
Quick Ratio
-1.43%
Cash Position Ratio
-1.42%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CYTX | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -61.59% | 1.07% | -8.14% | -11.28% |
| Return on assets | -17.41% | -21.62% | -6.71% | -9.53% |
| Return on sales | -657.87% | -5539.23% | 0% | -329.56% |
| Return on invested capital | 58.58% | 301.48% | -259.37% | -130.53% |
| Profitability | 5% | 50% | 50% | 0% |
| Total debt ratio | 70.73% | 142.14% | 23.84% | 22.13% |
| Debt ratio change over time | -1.03% | 0.23% | -0.97% | -1.29% |
| Dept financing | 12% | 50% | 4% | 4% |
| Current Ratio | 0.51% | 13.02% | 6.83% | 11.05% |
| Quick Ratio | 0.34% | 0% | 0% | 10.69% |
| Cash Position Ratio | 0.3% | 12.6% | 2.56% | 2.63% |
| Liquididy | 7% | 44% | 24% | 60% |
| Short-term ratios | CYTX | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -69.99% | -33.15% | -14.36% | -5.02% |
| Return on assets | -14.65% | -15.13% | -9.55% | -6.38% |
| Return on sales | -437.34% | -13599.98% | 0% | -333.95% |
| Return on invested capital | 135.82% | 571.73% | -381.13% | 16.96% |
| Profitability | 6% | 25% | 25% | 51% |
| Total debt ratio | 79.39% | 48.84% | 23.99% | 33.94% |
| Debt ratio change over time | -0.37% | -0.68% | -1.37% | -1.49% |
| Dept financing | 50% | 15% | 8% | 11% |
| Current Ratio | 0.51% | 13.02% | 6.83% | 11.05% |
| Quick Ratio | 0.34% | 0% | 0% | 10.69% |
| Cash Position Ratio | 0.3% | 12.6% | 2.56% | 2.63% |
| Liquididy | 2% | 50% | 18% | 51% |